Trial Profile
Efficacy and safety of dulaglutide when used instead of exenatide extended-release in type 2 diabetic patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 May 2019
Price :
$35
*
At a glance
- Drugs Dulaglutide (Primary) ; Exenatide
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 10 May 2019 Status changed from recruiting to completed.
- 19 Sep 2015 New trial record